Can anticoagulants be safely administered to patients with congenital protein C or S deficiency, and what considerations are necessary to prevent thrombotic or bleeding complications during therapy?
Gaurav ChauhanContributor
Can anticoagulants be safely used in patients with congenital protein C or S deficiency?
Share
Yes, anticoagulants can be used in patients with protein C or S deficiency, but it’s vital they are closely monitored for both clotting and bleeding risks.
Anticoagulation in patients with protein C or S deficiency requires careful dose management and frequent monitoring to balance the risks of thrombosis and bleeding.
When treating protein C or S deficiency with anticoagulants, bridging with heparin and careful INR control are necessary to ensure patient safety.